Objective: Bioresorbable vascular grafts are biologically active grafts that are entirely reconstituted by host-derived cells through an inflammation-mediated degradation process. Calcification is a detrimental condition that can severely affect graft performance. Therefore, prevention of calcification is of great importance to the success of bioresorbable arterial vascular grafts. The objective of this study was to test whether fast-degrading (FD) bioresorbable arterial grafts with high cellular infiltration will inhibit calcification of grafts.
For patients with cardiovascular diseases, creating clinically acceptable prosthetic small-diameter arterial grafts (<6 mm) as alternatives to autologous arterial or venous substitutes is paramount because of insufficient availability of autografts in patients with widespread atherosclerotic vascular disease. 1 Bioresorbable vascular grafts have emerged as a potentially suitable replacement to prosthetic grafts. Bioresorbable vascular grafts are biologically active grafts that over time are entirely reconstituted by host-derived cells through an inflammation-mediated scaffold degradation process. 2 The application of bioresorbable vascular grafts has several advantages to other implantable prosthetics, such as continuous growth potential, favorable biocompatibility, and low risk of infection or rejection. In addition, clinical evidence has now shown that bioresorbable vascular grafts are safe and effective to use in pediatric patients undergoing extracardiac total cavopulmonary connection procedures. 3, 4 We reported feasible late-term results (mean follow-up, 5.8 years) of tissue engineered vascular grafts for pediatric patients with congenital heart disease. 4 However, even with these advances, calcification, which could lead to thrombosis or graft rupture, remains one of the most detrimental events for long-term arterial vascular graft success. Preventing calcification is thus of the utmost importance in longterm success of arterial vascular grafts.
The scaffold material and structure play a crucial role in preventing calcification of grafts. A fast-degrading (FD) elastomer, prepared from an elastic polymer, was shown to develop well-organized neotissue in a rapid remodeling process (within 90 days) without any calcification up to 1 year later. 5, 6 On the basis of this finding, we hypothesized that FD bioresorbable arterial vascular grafts with high cellular infiltration will inhibit calcification of grafts.
To test this hypothesis, we created two versions of the grafts, slow-degrading (SD) grafts and FD grafts. Both grafts have the same inner layer composed of a 50:50 poly(L-lactic-co-ε-caprolactone) copolymer (PLCL) scaffold. However, the outer layer of SD grafts was composed of poly(L-lactic acid) (PLA) nanofibers, whereas the outer layer of FD grafts was composed of a combination of PLA and polyglycolic acid (PGA) nanofibers.
METHODS
Bioresorbable arterial vascular grafts. We created two versions of bioresorbable arterial vascular grafts, SD grafts and FD grafts. Both grafts have the same inner layer composed of a 50:50 PLCL scaffold. The scaffolds were constructed by pouring a solution of PLCL into a glass tube, then freeze-drying under a vacuum as previously described. 7 Next, these scaffolds were reinforced by electrospinning fibers in the outer layer. The outer layer of SD grafts was composed of PLA nanofibers, whereas the outer layer of FD grafts was composed of a combination of PLA and PGA nanofibers. The proportion of the PLA and PGA nanofibers is 50:50. The thickness of the nanofiber layer and the inner layer in either group is around 40 mm and 200 mm, respectively. Luminal diameter of each graft was around 600 mm (Fig 1, A and B) .
Animal model and surgical implantation. All animals received humane care in compliance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals. C57BL/6 mice were purchased from Jackson Laboratories (Bar Harbor, Me). Mean arterial pressure of C57BL/6 mice is 110 6 2 mm Hg. 8 The grafts of 3 mm in length were implanted in 8-to 10-week-old female mice (n ¼ 15 in the SD group, n ¼ 10 in the FD group) as infrarenal aortic interposition conduits using standard microsurgical techniques (Fig 1, C) . Low-pressure vascular clamps (Fine Science Tools, Foster City, Calif) were used for cross-clamping, and 400 U/kg of heparin was injected intramuscularly 5 minutes before unclamping. The graft was anastomosed with a running suture of 10-0 polypropylene. Animals were observed for 8 weeks to evaluate neotissue formation. An aspirinmixed diet (0.1% of diet) was fed to mice of each group 3 days before and 3 days after surgery to prevent acute thrombosis.
Histology, immunohistochemistry, and immunofluorescence. Explanted grafts at 8 weeks after implantation were fixed in 4% paraformaldehyde, embedded in paraffin, sliced (5-mm-thick sections), and stained with hematoxylin and eosin (H&E) and von Kossa stains. Outer and luminal perimeters of the grafts were manually measured from H&E staining with ImageJ software (National Institutes of Health, Bethesda, Md) to obtain luminal diameter and wall thickness measurements. Polarized microscopic images of H&E staining indicate the remaining polymer as white. One representative section from each explant was stained and imaged, which was used to measure the area fraction of the remaining polymer with ImageJ software. H&E staining was used for cell counting. One representative section from each explant was stained and imaged. Low-magnification (5Â) images were divided into nine sections (3 Â 3). Four of these regions (upper middle, center, lower right, and lower left) were selected to obtain high-magnification (20Â) images, the area of which was 0.12 mm 2 . All positively stained nuclei were counted from high-magnification images. Averages from these four regions represented the number of cells in each section. Identification of M1 macrophages and M2 macrophages was done by immunofluorescent staining of paraffin-embedded explant sections with rat anti-MAC3 antibody (1:75l; Dako, Carpinteria, Calif), mouse anti- RNA extraction and reverse transcription quantitative polymerase chain reaction. Explanted grafts at 8 weeks after implantation were frozen in optimal cutting temperature (OCT) compound (Sakura Finetek, Torrance, Calif) and sectioned into 20 sections of 30 mm. Total RNA was extracted and purified using the RNeasy mini kit (Qiagen, Valencia, Calif) according to the manufacturer's instructions. Reverse transcription was performed using a High Capacity RNA-to-cDNA Kit (Applied Biosystems, Foster City, Calif). All reagents and instrumentation for gene expression analysis were obtained from Applied Biosystems. Quantitative polymerase chain reaction was performed with a Step One Plus Real-Time PCR System using the TaqMan Universal PCR Master Mix Kit. Reference numbers for primers are as follows: 
RESULTS
Animal survival. All mice in the FD group survived the 8-week implantation period with patent grafts. There were no complications, such as bleeding, acute thrombosis, or graft rupture, in the FD group. However, in the SD group, three mice were sacrificed because of lower limb paralysis from acute thrombosis. The grafts in the mice that survived were all patent. These findings were No significant difference in the quantitative morphometric analysis. H&E staining showed cell infiltration within the scaffold in both groups (Fig 2, A) . There was no statistical difference in the luminal diameter (SD, 699 6 128 mm; FD, 776 6 24 mm; P ¼ .09; Fig 2, B) or wall thickness (SD, 298 6 53 mm; FD, 293 6 15 mm; P ¼ .79; Fig 2, C) between the groups.
Less residual scaffold and greater number of cells infiltrated in the outer layer of FD grafts. H&E staining with polarized light microscopy was used for quantitative measurement of residual scaffold in each group (Fig 3, A) . There was significantly less residual scaffold in the outer layer in FD grafts than in SD grafts (SD, 16.8% 6 1.7%; FD, 14.1% 6 1.7%; P ¼ .005; Fig 3, C) Calcification occurred only in SD grafts, not in FD grafts. The von Kossa staining revealed that calcification occurred only in SD grafts (7 of 12), not in FD grafts (P < .01, c 2 test ; Fig 4) .
Comparable endothelialization and smooth muscle cell proliferation in both graft groups. Vascular endothelial cells serve as the cellular barrier between the blood and underlying tissue constituents. Endothelial cell dysfunction leads to the recruitment and infiltration of leukocytes that could contribute to calcification. To evaluate endothelialization and smooth muscle cell (SMC) proliferation in the grafts, CD31 and a-SMA staining was employed, respectively. A layer of endothelial cell coverage on the luminal surface of the graft followed by an SMC layer was observed in both groups (Fig 5, A) . For quantitative comparison of endothelialization between the groups, gene expression of Pecam1 and Nos3 in the grafts was measured and demonstrated no statistical difference Comparable gene expression of transcription factors for osteogenesis and osteoclastogenesis in both graft groups. One of the key transcription factors associated with osteogenesis and osteoclastogenesis is, respectively, BMP2 and RANKL. 10, 11 No significant difference in the macrophage infiltration into the grafts. Immunofluorescent staining with anti-MAC3, anti-iNOS, and anti-CD206 antibody demonstrated that both M1 and M2 macrophages infiltrated into the grafts in both groups (Fig 6, A) . 
DISCUSSION
In a previous report, we demonstrated well-organized neotissue formation in bioresorbable arterial grafts, including endothelial cell coverage on the luminal surface of the graft surrounded by SMCs 12 months after implantation in a mouse model. 12 However, calcification is one of the most detrimental events for bioresorbable arterial vascular grafts. 13 The literature has revealed that inflammation-dependent calcification in vessels is due to the accumulation of macrophages and that endstage calcification is concomitant with a reduction in inflammation. [14] [15] [16] These observations suggest that inflammation is involved in the initiation and propagation of calcific mineral deposition. 17 The literature also showed that an FD elastomer developed wellorganized neotissue in a rapid remodeling process, without any calcification in a rat aortic implantation model. 5 In addition, our previous work demonstrated that a bioresorbable arterial vascular graft, constructed of a PLA nanofiber, had abundant scaffold fibers remaining and increased inflammation in the neointima, which caused severe calcification. 18 On the basis of these findings, we hypothesized that FD grafts will leave fewer residual scaffold fragments, thereby producing less inflammation, and subsequently inhibit calcification of the grafts. In the present study, we demonstrated that calcification occurred only in SD grafts; there was no calcification in FD grafts, which had significantly less residual scaffold at 8 weeks.
Macrophages have a critical role in vascular neotissue formation of grafts. 19 There is a lot of literature supporting the critical role of monocytes and macrophages in various types of vascular repair or remodeling processes. [20] [21] [22] In addition, macrophage-related inflammation is understood to be a key contributor to osteogenesis in the early stages of atherosclerotic intimal calcification. 15 Macrophages are involved in the early, proinflammatory phase of calcification by releasing extracellular vesicles containing a phosphatidylserineannexin V-S100A9 complex that facilitates mineral nucleation. 23 These procalcific macrophages exhibit a proinflammatory M1 macrophage phenotype. We assumed that the increased amounts of fragmented scaffold polymer in the SD group polarized the macrophages into the M1 macrophage phenotype, which led to calcification of the graft. However, the role of macrophage polarization in cardiovascular calcification remains largely unexplored. Nanofibers created by an electrospinning technique are a desirable material for fabricating bioresorbable arterial vascular grafts. Therefore, nanofiber-based scaffolds using biodegradable polymers have become a commonly used technique for constructing bioresorbable arterial vascular grafts; they have also demonstrated favorable surgical and mechanical properties with a high patency rate in arterial implantation models. [24] [25] [26] However, in our previous study, we demonstrated that the bioresorbable arterial vascular graft, which was constructed of SD PLA nanofibers, had severe calcification with abundant scaffold fragments remaining 12 months after implantation. 18 This led us to create an FD nanofiber layer by combining PLA and PGA nanofibers, which have a degradation period of 6 to 12 months and 2 to 3 weeks, respectively. 1 After the PGA in the outer layer of the FD graft degraded, inflammatory cells could infiltrate into the scaffold, thereby enabling the grafts to have both durability to the arterial pressure and inhibition of calcification because of fast scaffold degradation. We assessed the grafts at 8 weeks after implantation. This time period was based on our previous report, which showed organized vascular neotissue in the internal lumen of the scaffold after 6 weeks in the mouse aortic implantation model. 7 Therefore, an 8-week time point was deemed the optimal end point for evaluating neotissue formation of the graft. There are several limitations in this study. First, in this study, we demonstrated that calcification occurred only in the SD group, not in the FD group. However, we could not show the mechanism underlying the prevention of graft calcification. Although we assessed the relationship between calcification and macrophage phenotype by measuring the M1 and M2 macrophage markers, we could not show the statistical difference. Second, calcification of SD grafts appeared to have occurred exclusively in the inner layer; however, the differences between SD and FD graft composition, residual scaffold, or cell infiltration were confined to the outer layer of the grafts. Third, some mice had acute thrombosis after graft implantation. In our prior experiences, there was a propensity for acute thrombosis to occur at the percentage of 13% 27 to 40%. Thrombogenicity of the graft should be improved in the future experiments. Finally, the lumen size of the grafts increased approximately 10% for the SD group and 30% for the FD group 8 weeks after implantation. Actually, tensile strength of the SD grafts is greater than that of the FD grafts (data not shown). The nanofiber layer of the FD grafts may not be strong enough to endure arterial pressure, and it could be possible that aneurysmal formation will occur at a later time.
CONCLUSIONS
In this study, we demonstrated that calcification occurred only in the SD group, not in the FD group. Eight weeks after implantation, FD grafts had significantly less residual scaffold and greater numbers of cell infiltrate into the outer layer than in the SD grafts. The FD bioresorbable arterial vascular graft with high cellular infiltration shows promise for the prevention of graft calcification. and CD206 (M2 macrophage; white arrows). B, Gene expression was analyzed by reverse transcription quantitative polymerase chain reaction using the DDCT method. There was no statistical difference in gene expression of tumor necrosis factor a (TNFa) or iNOS between the groups (P ¼ .23 and .88, respectively). C, There was no statistical difference in gene expression of Mrc1 or Arg1 between the groups (P ¼ .69 and .89, respectively). FD, Fast-degrading graft; SD, slow-degrading graft.
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